123 related articles for article (PubMed ID: 17363577)
1. G-rich proto-oncogenes are targeted for genomic instability in B-cell lymphomas.
Duquette ML; Huber MD; Maizels N
Cancer Res; 2007 Mar; 67(6):2586-94. PubMed ID: 17363577
[TBL] [Abstract][Full Text] [Related]
2. AID binds to transcription-induced structures in c-MYC that map to regions associated with translocation and hypermutation.
Duquette ML; Pham P; Goodman MF; Maizels N
Oncogene; 2005 Sep; 24(38):5791-8. PubMed ID: 15940261
[TBL] [Abstract][Full Text] [Related]
3. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.
Pasqualucci L; Neumeister P; Goossens T; Nanjangud G; Chaganti RS; Küppers R; Dalla-Favera R
Nature; 2001 Jul; 412(6844):341-6. PubMed ID: 11460166
[TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous marginal zone B-cell lymphomas are targeted by aberrant somatic hypermutation.
Deutsch AJ; Frühwirth M; Aigelsreiter A; Cerroni L; Neumeister P
J Invest Dermatol; 2009 Feb; 129(2):476-9. PubMed ID: 18704108
[TBL] [Abstract][Full Text] [Related]
5. Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation.
Montesinos-Rongen M; Van Roost D; Schaller C; Wiestler OD; Deckert M
Blood; 2004 Mar; 103(5):1869-75. PubMed ID: 14592832
[TBL] [Abstract][Full Text] [Related]
6. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
7. Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity.
Nagaoka H; Tran TH; Kobayashi M; Aida M; Honjo T
Int Immunol; 2010 Apr; 22(4):227-35. PubMed ID: 20207715
[TBL] [Abstract][Full Text] [Related]
8. Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations.
Rowh MA; DeMicco A; Horowitz JE; Yin B; Yang-Iott KS; Fusello AM; Hobeika E; Reth M; Bassing CH
Oncogene; 2011 Nov; 30(47):4757-64. PubMed ID: 21625223
[TBL] [Abstract][Full Text] [Related]
9. Role of AID in tumorigenesis.
Okazaki IM; Kotani A; Honjo T
Adv Immunol; 2007; 94():245-73. PubMed ID: 17560277
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.
Shen RR; Ferguson DO; Renard M; Hoyer KK; Kim U; Hao X; Alt FW; Roeder RG; Morse HC; Teitell MA
Blood; 2006 Sep; 108(6):1991-8. PubMed ID: 16728701
[TBL] [Abstract][Full Text] [Related]
11. Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice.
Kotani A; Kakazu N; Tsuruyama T; Okazaki IM; Muramatsu M; Kinoshita K; Nagaoka H; Yabe D; Honjo T
Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1616-20. PubMed ID: 17251349
[TBL] [Abstract][Full Text] [Related]
12. AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature.
Pettersen HS; Galashevskaya A; Doseth B; Sousa MM; Sarno A; Visnes T; Aas PA; Liabakk NB; Slupphaug G; Sætrom P; Kavli B; Krokan HE
DNA Repair (Amst); 2015 Jan; 25():60-71. PubMed ID: 25486549
[TBL] [Abstract][Full Text] [Related]
13. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas.
Hallermann C; Kaune KM; Gesk S; Martin-Subero JI; Gunawan B; Griesinger F; Vermeer MH; Santucci M; Pimpinelli N; Willemze R; Siebert R; Neumann C
J Invest Dermatol; 2004 Jul; 123(1):213-9. PubMed ID: 15191563
[TBL] [Abstract][Full Text] [Related]
14. Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.
Rossi D; Gaidano G
Hematology; 2002 Aug; 7(4):239-52. PubMed ID: 14972786
[TBL] [Abstract][Full Text] [Related]
15. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.
Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4506-11. PubMed ID: 15767564
[TBL] [Abstract][Full Text] [Related]
16. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
[TBL] [Abstract][Full Text] [Related]
17. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.
Martín-Subero JI; Odero MD; Hernandez R; Cigudosa JC; Agirre X; Saez B; Sanz-García E; Ardanaz MT; Novo FJ; Gascoyne RD; Calasanz MJ; Siebert R
Genes Chromosomes Cancer; 2005 Aug; 43(4):414-23. PubMed ID: 15852472
[TBL] [Abstract][Full Text] [Related]
18. Somatic hypermutation and B-cell lymphoma.
Dunn-Walters D; Thiede C; Alpen B; Spencer J
Philos Trans R Soc Lond B Biol Sci; 2001 Jan; 356(1405):73-82. PubMed ID: 11205334
[TBL] [Abstract][Full Text] [Related]
19. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
[TBL] [Abstract][Full Text] [Related]
20. Long distance polymerase chain reaction for detection of chromosome translocations in B-cell lymphoma/leukemia.
Akasaka T; Ohno H; Mori T; Okuma M
Leukemia; 1997 Apr; 11 Suppl 3():316-7. PubMed ID: 9209376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]